Compare BIP & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIP | WST |
|---|---|---|
| Founded | 2007 | 1923 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 18.7B |
| IPO Year | 2008 | N/A |
| Metric | BIP | WST |
|---|---|---|
| Price | $36.52 | $228.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $41.25 | ★ $338.00 |
| AVG Volume (30 Days) | 492.7K | ★ 934.7K |
| Earning Date | 01-29-2026 | 02-12-2026 |
| Dividend Yield | ★ 4.87% | 0.37% |
| EPS Growth | N/A | ★ 0.17 |
| EPS | 0.70 | ★ 6.75 |
| Revenue | ★ $22,240,000,000.00 | $3,017,900,000.00 |
| Revenue This Year | N/A | $6.97 |
| Revenue Next Year | N/A | $6.27 |
| P/E Ratio | $50.34 | ★ $34.94 |
| Revenue Growth | ★ 8.14 | 4.92 |
| 52 Week Low | $25.72 | $187.43 |
| 52 Week High | $36.58 | $348.90 |
| Indicator | BIP | WST |
|---|---|---|
| Relative Strength Index (RSI) | 67.38 | 26.82 |
| Support Level | $34.50 | $232.06 |
| Resistance Level | $35.34 | $243.91 |
| Average True Range (ATR) | 0.70 | 8.80 |
| MACD | 0.20 | -4.03 |
| Stochastic Oscillator | 98.63 | 1.82 |
Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from USA and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.